Skip to main content

Jord BioScience Secures Series B Funding to Revolutionize Microbial Solutions for Agriculture

--News Direct--

Jord BioScience, a leading science and analytics company providing customizable microbial solutions for agriculture, announced the closing of its Series B round. This funding round will accelerate Jord BioScience's development and commercialization of innovative microbial technologies to deliver next-generation crop inputs.

Lead investor Silver Blue LLC, a Maryland-based firm focusing on agrifoodtech, was joined by Discovery Capital Funding, a matching equity investment program for University of Minnesota, Minnesota’s Small Business Credit Initiative (SSBCI) Direct Investment, and existing investors.

“This funding round marks a significant milestone for Jord BioScience, validating our partnership approach and the true potential of our microbial solutions to transform agriculture,” said Dr. Keri Carstens, president and CEO, Jord BioScience. “With this investment, we're poised to scale our operations to help biologicals and crop inputs companies accelerate product discovery and innovation for farmers worldwide.”

Founded on over 30 years of deep microbial science for agriculture by Jord BioScience’s Chief Science Officer Dr. Linda Kinkel, the company currently is partnering with leading agribusinesses to fast-track biological solutions by leveraging its expansive microbial bank of more than 6,500 microbial isolates. Collected from diverse global soils, these isolates enhance, protect, or promote distinct modes of action in major crops, including corn, soybeans, canola, and wheat as well as some specialty crops.

The Jord Microbial Bank is a premier collection of more than 6,500 microbial isolates from agriculturally relevant ecosystems, spanning diverse geographies, habitats, and soil chemistries.

“While biological innovation continues to evolve, Jord BioScience stands out by offering a fast and cost-effective approach to product differentiation, life cycle management, and revenue generation for agricultural companies. We believe Jord's technology can bring improved consistency of performance to the biological industry at a time when farmers are under pressure to produce more food while navigating financial and environmental pressures," said Francis Goelet, director, Silver Blue LLC. "We look forward to seeing the positive impact of Jord BioScience as the company continues to grow."

For more information about Jord BioScience, visit jordbioscience.com.

About Jord BioScience:

Jord BioScience, founded on research from the University of Minnesota, is a science and analytics company developing cutting-edge microbial technologies to enhance crop productivity and sustainability in agriculture. The company leverages over three decades of research by Dr. Linda Kinkel and her team, who collected thousands of unique soil microbes globally. Jord's proprietary technology and custom formulations are designed to extend product lifecycles, enhance crop performance, and expand market adoption of microbial solutions. From product concept through commercialization, Jord BioScience fast-tracks novel product development, reducing discovery from years to less than 10 months. This approach maximizes value and results in today's competitive marketplace. The company is currently conducting product development trials in the U.S., Argentina, and Brazil. For more information, visit www.jordbioscience.com

Contact Details

AgTech PR for Jord BioScience

Jennifer Goldston

jennifer@agtechpr.com

Company Website

https://www.jordbioscience.com

View source version on newsdirect.com: https://newsdirect.com/news/jord-bioscience-secures-series-b-funding-to-revolutionize-microbial-solutions-for-agriculture-172538812

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.